266 related articles for article (PubMed ID: 15793297)
1. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.
Dong Z; Bonfil RD; Chinni S; Deng X; Trindade Filho JC; Bernardo M; Vaishampayan U; Che M; Sloane BF; Sheng S; Fridman R; Cher ML
Am J Pathol; 2005 Apr; 166(4):1173-86. PubMed ID: 15793297
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
Nemeth JA; Yousif R; Herzog M; Che M; Upadhyay J; Shekarriz B; Bhagat S; Mullins C; Fridman R; Cher ML
J Natl Cancer Inst; 2002 Jan; 94(1):17-25. PubMed ID: 11773278
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated expression of TIMP-1 and TIMP-2 in bone inhibits osteolytic degradation by human prostate cancer.
Deng X; He G; Levine A; Cao Y; Mullins C
Int J Cancer; 2008 Jan; 122(1):209-18. PubMed ID: 17847032
[TBL] [Abstract][Full Text] [Related]
4. Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases.
Parikka V; Väänänen A; Risteli J; Salo T; Sorsa T; Väänänen HK; Lehenkari P
Matrix Biol; 2005 Sep; 24(6):438-47. PubMed ID: 16098718
[TBL] [Abstract][Full Text] [Related]
5. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
6. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.
Upadhyay J; Shekarriz B; Nemeth JA; Dong Z; Cummings GD; Fridman R; Sakr W; Grignon DJ; Cher ML
Clin Cancer Res; 1999 Dec; 5(12):4105-10. PubMed ID: 10632347
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth.
Bonfil RD; Dong Z; Trindade Filho JC; Sabbota A; Osenkowski P; Nabha S; Yamamoto H; Chinni SR; Zhao H; Mobashery S; Vessella RL; Fridman R; Cher ML
Am J Pathol; 2007 Jun; 170(6):2100-11. PubMed ID: 17525276
[TBL] [Abstract][Full Text] [Related]
8. Alendronate blocks metalloproteinase secretion and bone collagen I release by PC-3 ML cells in SCID mice.
Stearns ME; Wang M
Clin Exp Metastasis; 1998 Nov; 16(8):693-702. PubMed ID: 10211982
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
10. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.
Dahi S; Lee JG; Lovett DH; Sarkar R
J Vasc Surg; 2005 Sep; 42(3):539-45. PubMed ID: 16171603
[TBL] [Abstract][Full Text] [Related]
11. Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasis.
Nabha SM; Bonfil RD; Yamamoto HA; Belizi A; Wiesner C; Dong Z; Cher ML
Clin Exp Metastasis; 2006; 23(7-8):335-44. PubMed ID: 17136575
[TBL] [Abstract][Full Text] [Related]
12. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.
Xie Z; Yuan H; Yin Y; Zeng X; Bai R; Glazer RI
BMC Cancer; 2006 Mar; 6():77. PubMed ID: 16551362
[TBL] [Abstract][Full Text] [Related]
13. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
Lafleur MA; Drew AF; de Sousa EL; Blick T; Bills M; Walker EC; Williams ED; Waltham M; Thompson EW
Int J Cancer; 2005 Apr; 114(4):544-54. PubMed ID: 15551360
[TBL] [Abstract][Full Text] [Related]
15. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells.
Andersen TL; del Carmen Ovejero M; Kirkegaard T; Lenhard T; Foged NT; Delaissé JM
Bone; 2004 Nov; 35(5):1107-19. PubMed ID: 15542036
[TBL] [Abstract][Full Text] [Related]
16. Activation of fibroblast-derived matrix metalloproteinase-2 by colon-cancer cells in non-contact Co-cultures.
Ko K; Yazumi S; Yoshikawa K; Konda Y; Nakajima M; Chiba T; Takahashi R
Int J Cancer; 2000 Jul; 87(2):165-71. PubMed ID: 10861469
[TBL] [Abstract][Full Text] [Related]
17. Involvement of matrix metalloproteinases in the adipose conversion of 3T3-L1 preadipocytes.
Croissandeau G; Chrétien M; Mbikay M
Biochem J; 2002 Jun; 364(Pt 3):739-46. PubMed ID: 12049638
[TBL] [Abstract][Full Text] [Related]
18. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW
Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
Littlepage LE; Sternlicht MD; Rougier N; Phillips J; Gallo E; Yu Y; Williams K; Brenot A; Gordon JI; Werb Z
Cancer Res; 2010 Mar; 70(6):2224-34. PubMed ID: 20215503
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo.
Zhang W; Matrisian LM; Holmbeck K; Vick CC; Rosenthal EL
BMC Cancer; 2006 Mar; 6():52. PubMed ID: 16515711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]